Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. Issue 4 (July 2018) - Rakocevic, Goran; Martinez-Outschoorn, Ubaldo; Dalakas, Marinos C.